Abstract:
Provided are novel compounds which are capable of inhibiting an activity of RNA polymerase I, and uses thereof in treating diseases or disorders modulated by RNA polymerase I, preferably autoimmune diseases such as multiple sclerosis and proliferative diseases.
Abstract:
The present invention provides antibodies, as well as molecules having at least the antigen-binding portion of an antibody, recognizing a specific epitope of the protein CEACAM1 and optionally binds also other subtypes of the CEACAM protein family. Disclosed antibodies and antibody fragments are characterized by specific CDR sequences. Methods of production and use in therapy and diagnosis, of such antibodies and antibody fragments are also provided.
Abstract:
A method of providing an intraoperative magnetic resonance image of a target site of a patient body at which a medical procedure is performed, the method comprising: acquiring a high resolution preoperative magnetic resonance image (MRI), MRI0, of a first region of the patient comprising the target site, the MRI0 image comprising a plurality of slices MRI0 n having voxels; acquiring a preoperative, iMRI0 image of a second region of the patient comprising the target site, using an iMRI scanner having a field of view (FOV), the iMRI0 image comprising plurality of slices iMRI0 m having voxels; registering the MRI0 image to the iMRI0 image to provide a rigid body transform (RT0) that transforms the MRI0 to the iMRI0 image; acquiring an IMRI1 image of the target site during performance of the procedure; registering the image iMRI0 to the iMRIj image to obtain a non-rigid body transform (NRT); and applying RT0 and NRT to MRI0 to provide a high resolution (hiQ-iMRIj) image.
Abstract translation:一种提供执行医疗程序的患者身体的目标部位的术中磁共振图像的方法,所述方法包括:获取患者的第一区域的高分辨率术前磁共振图像(MRI)MRI0 所述MRI0图像包括具有体素的多个切片MRI0 n; 使用具有视场(FOV)的iMRI扫描仪获取包括所述目标部位的所述患者的第二区域的术前iMRI0图像,所述iMRI0图像包括具有体素的多个切片iMRI0 m; 将MRI0图像注册到iMRI0图像以提供将MRI0转换为iMRI0图像的刚体变换(RT0); 在执行程序期间获取目标站点的IMRI1图像; 将图像iMRI0注册到iMRIj图像以获得非刚体变换(NRT); 并将RT0和NRT应用于MRI0以提供高分辨率(hiQ-iMRIj)图像。
Abstract:
A method of tracking a region in a video image having a plurality of video frames is disclosed. The method comprises: generating one or more candidate contours in a video frame; and, for each candidate contour, analyzing the candidate contour based on intensity values of picture-elements along the candidate contour, and analyzing an area at least partially enclosed by the candidate contour based on texture features in the area. The method further comprises selecting a winner contour from the candidate contour(s) based on the analyses, and associating the region with the winner contour.
Abstract:
Methods of expressing a recombinant polypeptide of interest are provided. Accordingly there is provided a method comprising providing a cell having been contacted with an agent which downregulates an expression of a tuberous sclerosis (TSC) protein or directly inhibits an activity of same; and contacting the cell with a polynucleotide encoding the recombinant polypeptide of interest. Also provided is a method comprising contacting a cell with an agent which downregulates expression of a tuberous sclerosis (TSC) protein or directly inhibits an activity of same; and a polynucleotide encoding the recombinant polypeptide of interest. Also provided are isolated cells, cell cultures and articles of manufacture for recombinant expression of a recombinant polypeptide of interest.
Abstract:
Apparatus for operating MRI is disclosed. The apparatus comprises: a control for operating an MRI scanner to carry out an MRI scan; an input for receiving first and second MRI scans respectively at the beginning and end of a predetermined time interval post contrast administration; a subtraction map former for forming a subtraction map from the first and the second MRI scans by analyzing the scans to distinguish between a population in which contrast clearance from the tissue is slower than contrast accumulation, and a population in which clearance is faster than accumulation; and an output to provide an indication of distribution of the populations. The control is configured to carry out the first scan at least five minutes and no more than twenty minutes post contrast administration and to carry out the second scan such that the predetermined time period is at least twenty minutes.
Abstract:
A method for diagnosing a cancer characterized by over expression of CEACAM1 using an anti-CEACAM1 antibody or antibody fragment that recognizes CEACAM1 and comprises the same CDR sequences in the same orientation as the CDRs of the antibody produced from a hybridoma cell which has been deposited under ATCC Accession Number PTA-9974.
Abstract:
Compositions comprising an isolated peptide, which may for example optionally comprise a sequence selected from the group consisting of YDYNWY, YDYNLY, FDYNFY, FDYNLY, FDYNWY, YDWNLY, YDWHLY and WDYNLY, extracted from organisms such as aquatic organisms and mossor any other sequence described herein, and methods of using same, including for treatment of or prevention of formation of microbial biofilms and against adhesion of a cell to a surface.
Abstract:
The present invention is directed to methods for improving male fertility inter alia by increasing sperm count in a male subject. The methods of the invention comprise applying a positive electrical current below sensation level to at least one site of a scrotum of a subject in need thereof.
Abstract:
Methods and kits are provided for reversibly affixing an implant to a sclera of an eye of a subject. The methods and kits are based on applying a composition comprising at least one fibrin-based tissue adhesive to at least one of said implant and said sclera, thereby affixing said implant to the sclera, and applying a composition comprising at least one plasminogen activator to at least one of said implant and said sclera following a desired time-period, thereby detaching said implant from said sclera, and removing said implant from said eye.